[1]Yavropoulou MP,Makras P,Anastasilakis AD.Bazedoxifene for the treatment of osteoporosis[J].Expert Opin Pharmacother,2019,20(10):1201-1210.
[2]Wang PW,Li YZ,Zhuang HF,et al.Anti-osteoporosis medications associated with decreased mortality after hip fracture[J].Orthop Surg.2019,11(5):777-783.
[3]Amar AOS,Hyldstrup L,Nielsen J,et al.Intensive screening for osteoporosis in patients with hip fracture[J].Arch Osteoporos,2019,14(1):63.
[4]Cobden A,Cobden SB,Camurcu Y,et al.Effects of postoperative osteoporosis treatment on subsequent fracture and the 5-year survival rates after hemiarthroplasty for hip fracture[J].Arch Osteoporos,2019,14(1):100.
[5]Sheikh HQ,Hossain FS,Khan S,et al.Shortterm risk factors for a second hip fracture in a UK population[J].Eur J Orthop Surg Traumatol,2019,29(5):1055-1060.
[6]Xia WB,He SL,Xu L,et al.Rapidly increasing rates of hip fracture in Beijing,China[J].J Bone Miner Res,2011,27(1):125-129.
[7]Cooper C,Cole ZA,Holroyd CR,et al.Secular trends in the incidence of hip and other osteoporotic fractures[J].Osteoporos Int,2011,22(1):1277-1288.
[8]中国老年骨质疏松症诊疗指南(2018)工作组,中国老年学和老年医学学会骨质疏松分会,马远征,等.中国老年骨质疏松症诊疗指南(2018)[J].中华健康管理学杂志,2018,12(6):484.
[9]Roberts SE,Goldacre MJ.Time trends and demography of mortalityafter fractures neck of femur in an English population 1968—1998:database study[J].BMJ,2003,(327):771-775.
[10]Hossain M,Neelapala V,Andrew JC.Results of non-operativetreatment following hip fracture compared to surgical intervention[J].Injury,2009,40(4):418-421.